0001179110-13-013542.txt : 20130827 0001179110-13-013542.hdr.sgml : 20130827 20130827173613 ACCESSION NUMBER: 0001179110-13-013542 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130823 FILED AS OF DATE: 20130827 DATE AS OF CHANGE: 20130827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AASTROM BIOSCIENCES INC CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 24 FRANKL LLOYD WRIGHT DR STREET 2: PO BOX 376 CITY: ANN ARBOR STATE: MI ZIP: 48106 BUSINESS PHONE: 7349305555 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elliston Michael W. CENTRAL INDEX KEY: 0001585205 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 131063712 MAIL ADDRESS: STREET 1: AASTEROM BIOSCIENCES, INC. STREET 2: 24 FRANK LLOYD WRIGHT DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48105 3 1 edgar.xml FORM 3 - X0206 3 2013-08-23 0 0000887359 AASTROM BIOSCIENCES INC ASTM 0001585205 Elliston Michael W. C/O AASTROM BIOSCIENCES, INC. P.O. BOX 376 ANN ARBOR MI 48106 0 1 0 0 Controller Stock Option (right to buy) 1.86 2021-12-20 Common Stock 100000 D Stock Option (right to buy) 2.49 2022-05-03 Common Stock 50000 D These options were granted on December 20, 2011 with 25% vesting on the first anniversary of the date of grant and 6.25% vesting each quarter thereafter. These options were granted on May 3, 2012 and vest quarterly over four years commencing on the date of grant. /s/ Dominick C. Colangelo, attorney-in-fact 2013-08-27 EX-24.EXHIBIT 24 2 poaelliston.txt POWER OF ATTORNEY LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS Know all by these presents, that the undersigned's hereby makes, constitutes and appoints each of Dominick Colangelo and Mitchell S. Bloom as the undersigned's true and lawful attorney- in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to: (1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including any amendments thereto) with respect to the securities of Aastrom Biosciences, Inc., a Michigan corporation (the "Company"), with the United States Securities and Exchange Commission, any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act"); (2) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and (3) perform any and all other acts which in the discretion of such attorney-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing. The undersigned acknowledges that: (1) this Power of Attorney authorizes, but does not require, such attorney-in-fact to act in his or her discretion on information provided to such attorney-in-fact without independent verification of such information; (2) any documents prepared and/or executed by such attorney-in- fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable; (3) neither the Company nor such attorney-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirement of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and (4) this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act. The undersigned hereby gives and grants the foregoing attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to such attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 24th day of August, 2013. /s/ Michael W. Elliston ________________________________ Signature Michael W. Elliston _________________________________ Print Name